{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:13:05Z","timestamp":1777011185469,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Municipality of Oslo"},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Residents at nursing homes (NHs) are at particular risk for drug related harm. Regular medication reviews using explicit criteria for pharmacological inappropriateness and classification of drug related problems (DRPs) have recently been introduced as measures to improve the quality of medication use and for making the treatment more uniform across different institutions. Knowledge about variation in DRPs between NHs is scarce. To explore if increased attention towards more appropriate drug treatment in NHs have led to more uniform treatment, we have analyzed variations between different nursing homes\u2019 drug use and DRPs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cross-sectional medication review study including 2465 long-term care residents at 41 NHs in Oslo, Norway. Regular drug use was retrieved from the patients\u2019 medical records. DRPs were identified by using STOPP\/START and NORGEP criteria and a drug-drug interactions database. NHs were grouped in quartiles based on average levels of drug use. The upper and lower quartiles were compared using independent samples t-test and associations between drug use and DRPs were tested by logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients\u2019 mean age was 85.9\u2009years, 74.2% were women.<\/jats:p>\n                <jats:p>Mean numbers of regular drugs per patient was 6.8 and varied between NHs from 4.8 to 9.3.<\/jats:p>\n                <jats:p>The proportion of patients within each NH using psychotropic and analgesic drugs varied largely: antipsychotics from three to 50%, benzodiazepines from 24 to 99%, antidepressants from nine to 75%, anti-dementia drugs from no use to 42%, opioids from no use to 65% and paracetamol from 16 to 74%.<\/jats:p>\n                <jats:p>Mean DRPs per patient was 2.0 and varied between NHs from 0.5 to 3.4.<\/jats:p>\n                <jats:p>The quartiles of NHs with highest and lowest mean drugs per patient (7.7 vs. 5.7, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) had comparable mean number of DRPs per patient (2.2 vs. 1.8, <jats:italic>p<\/jats:italic>\u2009=\u20090.2). Using more drugs and the use of opioids, antipsychotics, benzodiazepines and antidepressants were associated with more DRPs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The use of psychotropic and analgesic drugs was high and varied substantially between different NHs. Even if the use of more drugs, opioids and psychotropic drugs was associated with DRPs, no difference was found in DRPs between the NHs with highest vs. lowest drug use.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-020-01745-y","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:22:47Z","timestamp":1599736967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Variation between nursing homes in drug use and in drug-related problems"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8337-7641","authenticated-orcid":false,"given":"Amura Francesca","family":"Fog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahimu","family":"Mdala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Engedal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rund","family":"Straand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"1745_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000433525","volume":"40","author":"AS Helvik","year":"2015","unstructured":"Helvik AS, Engedal K, Benth J\u0160, Selb\u00e6k G. Prevalence and severity of dementia in nursing home residents. Dement Geriatr Cogn Disord. 2015;40:166\u201377. https:\/\/doi.org\/10.1159\/000433525.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"1745_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/qhc.12.3.176","volume":"12","author":"S Ruths","year":"2003","unstructured":"Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District nursing home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176\u201380.","journal-title":"Qual Saf Health Care"},{"key":"1745_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/02813431003765455","volume":"28","author":"KH Halvorsen","year":"2010","unstructured":"Halvorsen KH, Ruths S, Granas AG, Viktil KK. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care. 2010;28:82\u20138.","journal-title":"Scand J Prim Health Care"},{"key":"1745_CR4","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1017\/S1041610216001150","volume":"28","author":"SI Janus","year":"2016","unstructured":"Janus SI, van Manen JG, Izerman MJ, Zuidema SU. Psychotropic drug prescriptions in Western European nursing homes. Int Psychogeriatr. 2016;28:1775\u201390. https:\/\/doi.org\/10.1017\/S1041610216001150.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1745_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/ageing\/afv184","volume":"45","author":"R Sandvik","year":"2016","unstructured":"Sandvik R, Selbaek G, Kirkevold O, Husebo BS, Aarsland D. Analgesic prescribing patterns in Norwegian nursing homes from 2000 to 2011: trend analyses of four data samples. Age Ageing. 2016;45(1):54\u201360. https:\/\/doi.org\/10.1093\/ageing\/afv184.","journal-title":"Age Ageing"},{"key":"1745_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12877-016-0287-1","volume":"16","author":"C Gulla","year":"2016","unstructured":"Gulla C, Selbaek G, Flo E, Kjome R, Kirkevold \u00d8, Husebo BS. Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011. BMC Geriatr. 2016;16:115. https:\/\/doi.org\/10.1186\/s12877-016-0287-1.","journal-title":"BMC Geriatr"},{"key":"1745_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12877-017-0440-5","volume":"17","author":"AS Helvik","year":"2017","unstructured":"Helvik AS, \u0160altyt\u0117 Benth J, Wu B, Engedal K, Selb\u00e6k G. Persistent use of psychotropic drugs in nursing home residents in Norway. BMC Geriatr. 2017;17:52. https:\/\/doi.org\/10.1186\/s12877-017-0440-5.","journal-title":"BMC Geriatr"},{"key":"1745_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2003","unstructured":"Mangoni AA, Jackson SHD. Age related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2003;57:6\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"1745_CR9","volume-title":"Nasjonal faglig retningslinje om demens (Guidelines for dementia)","author":"The Norwegian Directorate of Health","year":"2017","unstructured":"The Norwegian Directorate of Health. 2017; Nasjonal faglig retningslinje om demens (Guidelines for dementia). https:\/\/helsedirektoratet.no\/retningslinjer\/nasjonal-faglig-retningslinje-om-demens. Accessed on 14 Oct 2019."},{"key":"1745_CR10","unstructured":"National Institute for Health and Clinical Excellence. Dementia: supporting people with dementia and their carers in health and social care. https:\/\/guidance.nice.org.uk\/CG42. Accessed on 14 Oct 2019."},{"key":"1745_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","volume":"14","author":"L Schneider","year":"2006","unstructured":"Schneider L, Dagerman K, Insel P. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomised, placebo-controlled trials. Am J Geriatr Psychiatr. 2006;14:191\u2013210.","journal-title":"Am J Geriatr Psychiatr"},{"key":"1745_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s002280100348","volume":"57","author":"S Ruths","year":"2001","unstructured":"Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes \u2013 diagnostic indications and variations between institutions. Eur J Clin Pharmacol. 2001;57:523\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"1745_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/JMDH.S15773","volume":"4","author":"M Davidsson","year":"2011","unstructured":"Davidsson M, Vibe OE, Ruths S, Blix HS. A multidisciplinary approach to improve drug therapy in nursing homes. J Multidisciplin Healthcare. 2011;4:9\u201323. https:\/\/doi.org\/10.2147\/JMDH.S15773.","journal-title":"J Multidisciplin Healthcare"},{"issue":"3","key":"1745_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1017\/S1463423611000685","volume":"13","author":"K Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger K, Folkestad M, Geitung JT, Eide GE, Grimsmo A. Psychoactive drugs in seven nursing homes. Prim Care Res Develop. 2012;13(3):244\u201354.","journal-title":"Prim Care Res Develop"},{"issue":"1","key":"1745_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12877-017-0428-1","volume":"17","author":"H Cioltan","year":"2017","unstructured":"Cioltan H, Alshehri S, Howe C, Lee J, Fain M, Eng H, Scachter K, Mohler J. Variation in use of antipsychotic medications in nursing homes in the United States: a systematic review. BMC Geriatr. 2017;17(1):32. https:\/\/doi.org\/10.1186\/s12877-017-0428-1.","journal-title":"BMC Geriatr"},{"key":"1745_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs15766","volume":"67","author":"American Geriatrics Society","year":"2019","unstructured":"American Geriatrics Society. Updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. J Am Geriatrics Society Vol. 2019;67:674\u201394. https:\/\/doi.org\/10.1111\/jgs15766.","journal-title":"J Am Geriatrics Society Vol"},{"key":"1745_CR17","doi-asserted-by":"publisher","unstructured":"Alldred DP, Raynor DK, Hughes C, Barber N, Chen TF, Spoor P. Interventions to optimize prescribing for older people in care homes. Cochrane Database Syst Rev. 2013;(2):CD009095. https:\/\/doi.org\/10.1002\/14651858.CD009095.pub2.","DOI":"10.1002\/14651858.CD009095.pub2"},{"key":"1745_CR18","unstructured":"The Norwegian Directorate of Health. 2012; Veileder om legemiddelgjennomganger (Guidelines for medication reviews). https:\/\/helsedirektoratet.no\/Lists\/Publikasjoner\/Attachments\/465\/Veileder-legemiddelgjennomgang_IS_1998.pdf. Accessed on 14 Oct 2019."},{"key":"1745_CR19","volume-title":"Classification for drug-related problems","author":"Pharmaceutical Care Network Europe","year":"2006","unstructured":"Pharmaceutical Care Network Europe. Classification for drug-related problems. 2006. https:\/\/www.pcne.org\/. Accessed on 14 Oct 2019."},{"key":"1745_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4045\/tidsskr.09.34953","volume":"129","author":"H Kersten","year":"2009","unstructured":"Kersten H, Ruths S, Wyller TB. Farmakoterapi i sykehjem (pharmacotherapy in nursing homes). Tidssk Nor Legeforen. 2009;129:9\u201312.","journal-title":"Tidssk Nor Legeforen"},{"key":"1745_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/02813432.2017.1397246","volume":"35","author":"AF Fog","year":"2017","unstructured":"Fog AF, Kvalvaag G, Engedal K, Straand J. Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo. Norway Scand J Prim Health Care. 2017;35:329\u201335. https:\/\/doi.org\/10.1080\/02813432.2017.1397246.","journal-title":"Norway Scand J Prim Health Care"},{"key":"1745_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5414\/CPP46072","volume":"46","author":"P Gallager","year":"2008","unstructured":"Gallager P, Ryan C, Byrne S, Kennedy J, O\u2019Mahony D. STOPP (screening tool of older Person\u2019s prescriptions) and START (screening tool to alert doctors to right treatment). Int J Clin Pharmacol Ther. 2008;46:72\u201383.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1745_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/02813430902992215","volume":"27","author":"S Rognstad","year":"2009","unstructured":"Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J. The Norwegian general practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. Scand J Prim Health Care. 2009;27:153\u20139.","journal-title":"Scand J Prim Health Care"},{"key":"1745_CR24","unstructured":"Interaksjonsdatabase for norske klinikere FEST (tidligere DRUID) [Drug-drug interaction database for Norwegian clinicians (previous DRUID database)] http:\/\/www.interaksjoner.no Accessed 14 Oct 2019."},{"key":"1745_CR25","first-page":"3073","volume":"127","author":"S Ruths","year":"2007","unstructured":"Ruths S, Viktil KK, Blix HS. Klassifisering av legemiddelrelaterte problemer (Classification of drug-related problems). Tidskr Nor Legeforen. 2007;127:3073\u20136 PMID 18049498.","journal-title":"Tidskr Nor Legeforen"},{"key":"1745_CR26","volume-title":"Guidelines for ATC Classification and DDD Assignment","author":"WHO Collaborating Center for Drug Statistics Methodology","year":"2015","unstructured":"WHO Collaborating Center for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo: Norway: WHO collaborating Centre for Drug Statistics Methodology; 2015. https:\/\/www.whocc.no\/. Accessed 14 Oct 2019."},{"issue":"3","key":"1745_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1017\/S1041610213002019","volume":"26","author":"B Kleijer","year":"2014","unstructured":"Kleijer B, Van Marum R, Frijters D, Jansen PA, Ribbe MW, Egberts AC, Heerdink ER. Variability between nursing homes in prevalence of antipsychotic use in patients with dementia. Int Psychogeriatr. 2014;26(3):363\u201371. https:\/\/doi.org\/10.1017\/S1041610213002019.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1745_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/archinternmed.2009.469","volume":"170","author":"Y Chen","year":"2010","unstructured":"Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med. 2010;170(1):89\u201395. https:\/\/doi.org\/10.1001\/archinternmed.2009.469.","journal-title":"Arch Intern Med"},{"key":"1745_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/archinte.167.7.676","volume":"167","author":"PA Rochon","year":"2007","unstructured":"Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K, Wodchis WP, Hillmer M, Kopp A, Gurwitz JH, Anderson GM. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167:676\u201383.","journal-title":"Arch Intern Med"},{"issue":"4","key":"1745_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/pharmacy7040148","volume":"7","author":"KH Halvorsen","year":"2019","unstructured":"Halvorsen KH, Stadel\u00f8kken T, Garcia BH. A stepwise pharmacist-led medication review Service in Interdisciplinary Teams in rural nursing homes. Pharmacy (Basel). 2019;7(4):148. https:\/\/doi.org\/10.3390\/pharmacy7040148.","journal-title":"Pharmacy (Basel)"},{"key":"1745_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/02813432.2011.628240","volume":"29","author":"KR Iden","year":"2011","unstructured":"Iden KR, Hj\u00f8rleifsson S, Ruths S. Treatment decisions on antidepressants in nursing homes: a qualitative study. Scan J Primary Health Care. 2011;29:252\u20136.","journal-title":"Scan J Primary Health Care"},{"issue":"Suppl1","key":"1745_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ageing\/afs200","volume":"42","author":"A Abdulla","year":"2013","unstructured":"Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, Knaggs R, Martin D, Sampson L, Schofield P, British Geriatric Society. Guidance on the management of pain in older people (Review). Age Ageing. 2013;42(Suppl1):1\u201357. https:\/\/doi.org\/10.1093\/ageing\/afs200.","journal-title":"Age Ageing"},{"key":"1745_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40886-018-0076-y","volume":"4","author":"K Cappelen","year":"2018","unstructured":"Cappelen K, Harris A, Aase K. Variability in staff perceptions of patient safety culture in Norwegian nursing homes - a longitudinal cross-sectional study. Safety in Health. 2018;4:9. https:\/\/doi.org\/10.1186\/s40886-018-0076-y.","journal-title":"Safety in Health"},{"key":"1745_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000354366","volume":"36","author":"AM Rokstad","year":"2013","unstructured":"Rokstad AM, R\u00f8svik J, Kirkevold \u00d8, Selbaek G, Saltyte Benth J, Engedal K. The effect of person-centered dementia care to prevent agitation and other neuropsychiatric symptoms and enhance quality of life in nursing home patients: a 10-month randomized controlled trial. Dement Geriatr Cogn Disord. 2013;36:340\u201353. https:\/\/doi.org\/10.1159\/000354366.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1745_CR35","doi-asserted-by":"publisher","unstructured":"Romskaug R, Skovlund E, Straand J, Molden E, Kersten H, Pitkala KH, Lundqvist C, Wyller TB. Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving Polypharmacy: a cluster randomized clinical trial. JAMA Intern Med. Published on line October 16, 2019. https:\/\/doi.org\/10.1001\/jamainternmed.2019.5096.","DOI":"10.1001\/jamainternmed.2019.5096"},{"key":"1745_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/02813432.2015.1041833","volume":"33","author":"G Nyborg","year":"2015","unstructured":"Nyborg G, Straand J, Klovning A, Brekke M. The Norwegian general practice\u2013nursing home criteria (NORGEP-NH) for potentially inappropriate medication use: a web-based Delphi study. Scand J Prim Health Care. 2015;33:134\u201341.","journal-title":"Scand J Prim Health Care"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-020-01745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-020-01745-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-020-01745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T23:28:11Z","timestamp":1631143691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-020-01745-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1186\/s12877-020-01745-y","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"According to the Norwegian act on medical and health research, no formal ethical approval was needed for the present study. Formal consent was not required because data is anonymous. The study protocol of the medication review project at the nursing homes, which generated the data used here, was presented to the Regional Committee in Medical Research Ethics in South-East Norway (reference no. 2015\/786) and the Norwegian Centre for Research Data (reference no. 43659). Both bodies concluded that their formal approval was not needed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}